SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-12-039679
Filing Date
2012-07-16
Accepted
2012-07-16 17:18:30
Documents
6
Effectiveness Date
2012-07-16

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v318691_8k.htm DEFA14A 39072
2 EXHIBIT 2.1 v318691_ex2-1.htm EX-2.1 488328
3 EXHIBIT 4.1 v318691_ex4-1.htm EX-4.1 30136
4 EXHIBIT 99.1 v318691_ex99-1.htm EX-99.1 16491
5 EXHIBIT 99.2 v318691_ex99-2.htm EX-99.2 15194
6 GRAPHIC logo.jpg GRAPHIC 18825
  Complete submission text file 0001144204-12-039679.txt   616385
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-10827 | Film No.: 12964269
SIC: 2834 Pharmaceutical Preparations